Product
Book a demo
Product
Book a Demo

PrescribeIT Ending: What Canadian Providers Need to Know About Open e-Prescribing

7 May 2026
Stefan Swanepoel
Contents

Canada Health Infoway has officially announced that the PrescribeIT service will end on May 29, 2026. This national e-prescribing platform, which allowed physicians and nurse practitioners to send prescriptions electronically from their EMR directly to pharmacies, will cease operations as part of a shift toward an open-standards e-prescribing model.

This change creates both challenges and opportunities. Understanding the timeline, implications, and preparation steps is essential to maintain safe, efficient prescribing workflows with minimal disruption to patient care.

Why PrescribeIT Is Ending

Launched in 2018, PrescribeIT was developed by Canada Health Infoway to replace fax and paper prescriptions with a secure, national electronic solution. Despite technical success and integration with many EMRs and pharmacy systems, the service did not achieve the widespread adoption needed for long-term sustainability.

After consultations with provinces, territories, and stakeholders, Infoway decided to wind down the centrally operated service. Instead, Canada is moving to a more flexible open-standards approach that allows provinces, EMR vendors, and technology providers to develop interoperable e-prescribing solutions tailored to local needs.

The service will remain fully operational until May 29, 2026, at 11:59 PM EST. After this date, Infoway will no longer operate PrescribeIT, and a national e-prescribing standard will be made publicly available to support the transition.

Key Dates and What Changes for Canadian Providers

  • Service conclusion: May 29, 2026 (11:59 PM EST)
  • National open standard release: Expected before the service ends (targeted around May 1, 2026)
  • No central replacement: Infoway will not launch a new operated e-prescribing service

Practices currently using PrescribeIT for new prescriptions, renewals, and certain monitored drugs (including TPP Type 1 medications under existing exemptions) will need to adapt. The exemption tied specifically to PrescribeIT for electronically transmitting monitored drugs will also end with the service.

This transition affects family physicians, specialists, nurse practitioners, and multidisciplinary teams who have integrated electronic prescribing into their daily workflows.

Impact on Your Canadian Practice

The end of PrescribeIT does not mean the end of e-prescribing in Canada. However, it will require adjustments in how prescriptions are transmitted securely and compliantly.

Main implications include:

  • Potential changes to prescription workflows in your EMR
  • Need to verify new integration options with your EMR vendor
  • Continued compliance with PHIPA for protecting personal health information
  • Maintaining clear communication with local pharmacies
  • Possible updates to processes for monitored medications under Canadian regulations

The move to open standards e-prescribing offers greater flexibility. Provinces and vendors can now innovate faster, potentially leading to better integration with Canada’s existing digital health infrastructure and improved support for virtual care and team-based models.

Actionable Steps to Prepare for the PrescribeIT Transition

Canadian healthcare providers should start preparing well before the May 2026 deadline. Here’s a practical checklist:

  1. Contact your EMR vendor today - Ask specifically about their roadmap for supporting open-standards e-prescribing after PrescribeIT ends. Inquire about interim solutions and timelines for compliance with the new national standard.
  2. Assess your current prescribing volume - Review how many prescriptions currently flow through PrescribeIT versus fax or printed methods. This helps gauge the scale of change required.
  3. Monitor official updates - Watch for the release of the national e-prescribing standard from Canada Health Infoway.
  4. Engage with your local pharmacies - Discuss their plans for receiving electronic prescriptions post-May 2026. Strong collaboration remains key to safe medication management.
  5. Review regulatory requirements - Confirm updated rules around electronic transmission of monitored drugs with the College of Physicians and Surgeons of Ontario (CPSO) or your relevant regulatory college.
  6. Plan staff training and patient communication - Prepare your team and develop simple messaging for patients if any changes to prescription processes occur.
  7. Ensure data security and backups - Maintain robust, PHIPA-compliant data practices throughout the transition.

GoodX Healthcare clients benefit from dedicated support to align their EMR with these evolving requirements while minimizing disruption to clinical workflows.

The Future of E-Prescribing in Canada

The PrescribeIT wind-down reflects broader realities in Canadian digital health: national platforms often struggle with adoption and sustainable funding across jurisdictions. The open-standards model aims to overcome these barriers by promoting interoperability without relying on a single central service.

This approach could accelerate innovation, giving Canadian providers access to more tailored, efficient tools that better integrate with provincial programs, OHIP billing, and team-based care models.

Ultimately, the goal stays the same, reducing medication errors, improving patient safety, enhancing privacy, and freeing up valuable time for direct patient care.

How GoodX Healthcare Supports Canadian Practices During This Transition

At GoodX Healthcare, we provide PHIPA-compliant EMR solutions designed specifically for healthcare providers, including family practices, specialists, and multidisciplinary teams. Our platform focuses on reliability, efficiency, and adaptability during periods of regulatory and technological change.

We actively track developments related to the PrescribeIT service ending and work closely with technology partners to ensure continuity in prescribing workflows. Whether you need guidance on current integrations, preparation for open-standards e-prescribing, or support with OHIP billing and practice optimization, our team is ready to assist.

If your practice is evaluating EMR options or planning for smoother digital transitions, GoodX offers secure data migration and ongoing compliance support.

Final Recommendations

The PrescribeIT service ending on May 29, 2026 marks an important shift in Canada’s approach to e-prescribing. By taking proactive steps now, especially engaging your EMR vendor and staying informed about the upcoming national standard, healthcare providers can ensure a smooth transition with continued focus on medication safety and patient care.

Change is inevitable in healthcare technology, but preparation transforms potential disruption into an opportunity for improved workflows and better outcomes.

Stay updated through official channels from Canada Health Infoway and regulatory bodies. For personalized support with your EMR during this transition, reach out to the GoodX Healthcare team.

Resources

This article is for informational purposes only and does not replace professional regulatory or legal advice. Consult your EMR provider, college, and legal advisor for practice-specific guidance. Information is current as of April 2026.

menu